A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects Than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer's Disease

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Sep 9

PMID 36078067

Authors

Sudhir Kshirsagar

Rainier Vladlen Alvir

Jangampalli Adi Pradeepkiran

Ashly Hindle

Murali Vijayan

Bhagavathi Ramasubramaniam

Subodh Kumar

Arubala P Reddy

P Hemachandra Reddy

Affiliations

Soon will be listed here.

Abstract

In the current study, for the first time, we study mitophagy enhancer urolithin A and a combination of urolithin A+green tea extract EGCG against human Aβ peptide-induced mitochondrial and synaptic, dendritic, inflammatory toxicities and behavioral changes in humanized homozygous amyloid beta knockin (hAbKI) mice of late-onset Alzheimer's disease (AD). Our findings reveal significantly increased positive effects of urolithin A and a combination treatment of urolithin A+EGCG in hAbKI mice for phenotypic behavioral changes including motor coordination, locomotion/exploratory activity, spatial learning and working memory. mRNA and protein levels of mitochondrial fusion, synaptic, mitophagy and autophagy genes were upregulated, and mitochondrial fission genes are downregulated in urolithin A and combine treatment in hAbKI mice; however, the effect is stronger in combined treatment. Immunofluorescence analysis of hippocampal brain sections shows similar findings of mRNA and protein levels. Mitochondrial dysfunction is significantly reduced in both treatment groups, but a stronger reduction is observed in combined treatment. Dendritic spines and lengths are significantly increased in both treatment groups, but the effect is stronger in combined treatment. The fragmented number of mitochondria is reduced, and mitochondrial length is increased, and mitophagosomal formations are increased in both the groups, but the effect is stronger in the combined treatment. The levels of amyloid beta (Aβ) 40 and Aβ42 are reduced in both treatments, however, the reduction is higher for combined treatment. These observations suggest that urolithin A is protective against human Aβ peptide-induced toxicities; however, combined treatment of urolithin A+EGCG is effective and stronger, indicating that combined therapy is promising to treat late-onset AD patients.

Citing Articles

Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.

Anchimowicz J, Zielonka P, Jakiela S Int J Mol Sci. 2025; 26(1.

PMID: 39796234 PMC: 11720160. DOI: 10.3390/ijms26010380.

Use and Reuse of Animal Behavioral, Molecular, and Biochemical Data in Alzheimer's Disease Research: Focus on 3Rs and Saving People's Tax Dollars.

Islam M, Kshirsagar S, Reddy A, Sehar U, Reddy P J Alzheimers Dis Rep. 2024; 8(1):1171-1184.

PMID: 39247873 PMC: 11380314. DOI: 10.3233/ADR-240126.

Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.

Hou Y, Chu X, Park J, Zhu Q, Hussain M, Li Z Alzheimers Dement. 2024; 20(6):4212-4233.

PMID: 38753870 PMC: 11180933. DOI: 10.1002/alz.13847.

Urolithins: A Prospective Alternative against Brain Aging.

An L, Lu Q, Wang K, Wang Y Nutrients. 2023; 15(18).

PMID: 37764668 PMC: 10534540. DOI: 10.3390/nu15183884.

Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease.

Sousa T, Moreira P, Cardoso S Biomedicines. 2023; 11(9).

PMID: 37760774 PMC: 10525414. DOI: 10.3390/biomedicines11092331.

References

Reddy P, Tripathi R, Troung Q, Tirumala K, Reddy T, Anekonda V . Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta. 2011; 1822(5):639-49. PMC: 3272314. DOI: 10.1016/j.bbadis.2011.10.011. View

Reddy P, Manczak M, Mao P, Calkins M, Reddy A, Shirendeb U . Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. J Alzheimers Dis. 2010; 20 Suppl 2:S499-512. PMC: 3059092. DOI: 10.3233/JAD-2010-100504. View

Hirai K, Aliev G, Nunomura A, Fujioka H, Russell R, Atwood C . Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001; 21(9):3017-23. PMC: 6762571. View

Manczak M, Reddy P . Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet. 2012; 21(11):2538-47. PMC: 3349426. DOI: 10.1093/hmg/dds072. View

Chang X, Rong C, Chen Y, Yang C, Hu Q, Mo Y . (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression. Exp Cell Res. 2015; 334(1):136-45. DOI: 10.1016/j.yexcr.2015.04.004. View

John A, Reddy P . Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev. 2020; 65:101208. PMC: 7770124. DOI: 10.1016/j.arr.2020.101208. View

Morton H, Kshirsagar S, Orlov E, Bunquin L, Sawant N, Boleng L . Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse. Free Radic Biol Med. 2021; 172:652-667. DOI: 10.1016/j.freeradbiomed.2021.07.013. View

Selkoe D . Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001; 81(2):741-66. DOI: 10.1152/physrev.2001.81.2.741. View

Wang X, Su B, Siedlak S, Moreira P, Fujioka H, Wang Y . Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A. 2008; 105(49):19318-23. PMC: 2614759. DOI: 10.1073/pnas.0804871105. View

10.

Reddy P, McWeeney S . Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol Aging. 2005; 27(8):1060-77. DOI: 10.1016/j.neurobiolaging.2005.04.014. View

11.

Mega M, Cummings J, Fiorello T, Gornbein J . The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996; 46(1):130-5. DOI: 10.1212/wnl.46.1.130. View

12.

Mattson M . Pathways towards and away from Alzheimer's disease. Nature. 2004; 430(7000):631-9. PMC: 3091392. DOI: 10.1038/nature02621. View

13.

Wei Y, Liu D, Zheng Y, Hao C, Li H, Ouyang W . Neuroprotective Effects of Kinetin Against Glutamate-Induced Oxidative Cytotoxicity in HT22 Cells: Involvement of Nrf2 and Heme Oxygenase-1. Neurotox Res. 2017; 33(4):725-737. DOI: 10.1007/s12640-017-9811-0. View

14.

Manczak M, Kandimalla R, Fry D, Sesaki H, Reddy P . Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease. Hum Mol Genet. 2016; 25(23):5148-5166. PMC: 6078633. DOI: 10.1093/hmg/ddw330. View

15.

Silva D, Selfridge J, Lu J, E L, Roy N, Hutfles L . Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum Mol Genet. 2013; 22(19):3931-46. PMC: 3888119. DOI: 10.1093/hmg/ddt247. View

16.

Reddy P, Oliver D . Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Cells. 2019; 8(5). PMC: 6562604. DOI: 10.3390/cells8050488. View

17.

Manczak M, Kandimalla R, Yin X, Reddy P . Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum Mol Genet. 2018; 28(2):177-199. PMC: 6322070. DOI: 10.1093/hmg/ddy335. View

18.

Oliver D, Reddy P . Molecular Basis of Alzheimer's Disease: Focus on Mitochondria. J Alzheimers Dis. 2019; 72(s1):S95-S116. DOI: 10.3233/JAD-190048. View

19.

Du H, Guo L, Fang F, Chen D, Sosunov A, McKhann G . Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med. 2008; 14(10):1097-105. PMC: 2789841. DOI: 10.1038/nm.1868. View

20.

Reddy A, Yin X, Sawant N, Reddy P . Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease. Hum Mol Genet. 2021; 30(10):847-864. PMC: 8355469. DOI: 10.1093/hmg/ddab054. View